SCHEMBL163389

SCHEMBL163389

O=C1C=CC(=O)N1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL6096372 0.96 MGLL (0.42)
SCHEMBL157324 0.67 MGLL (0.50)
SCHEMBL28676621 0.64
SCHEMBL19046582 0.62
SCHEMBL4340966 0.62
SCHEMBL18389677 0.62 MGLL (0.45)
SCHEMBL16104380 0.61
SCHEMBL2434186 0.61
SCHEMBL718436 0.61
SCHEMBL8135505 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2857 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075736-A Tumor microenvironment responsive enzyme prodrug conversion nano-composite and preparation method thereof 2026-05-26 CN claimed
CN-122057044-A Nanometer liposome delivery system for targeting PLK1/Aurora kinase and application thereof in oral squamous cell carcinoma treatment 徐州医科大学 2026-05-19 CN claimed
CN-122036883-A Affinity purification process for human serum albumin and DARPin dimer ligand 无锡萃纯生物材料科技有限公司 2026-05-15 CN claimed
US-20260069709-A1 EXTRACELLULAR VESICLE HYDROGELS AND USE THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2026-03-12 US claimed
CN-121577572-A Terahertz probe with target recognition and cascade signal amplification functions 中国人民解放军总医院第一医学中心 2026-02-27 CN claimed
EP-4683964-A2 POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF Ocular Therapeutix, Inc. (US) 2026-01-28 EP claimed
US-20260014271-A1 METABOLIC TAGGING AND TARGETING OF RED BLOOD CELLS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2026-01-15 US claimed
US-20250387466-A1 COMPOSITIONS OF NUCLEIC ACID NANOSTRUCTURES FOR VACCINES AND METHODS OF USE THEREOF MASSACHUSETTS INST TECHNOLOGY (US) 2025-12-25 US claimed
US-20250339543-A1 POLYMER-BASED CONJUGATE, COMPRISING POLYPROPYLENE OXIDE, FOR IMPROVING THERAPEUTIC EFFECTS OF ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES CATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION (KR) 2025-11-06 US claimed
US-20250333425-A1 HETEROAROMATIC SILICON-FLUORIDE-ACCEPTORS USEFUL FOR 18F LABELING OF MOLECULES AND BIOMOLECULES, AND METHODS OF PREPARING SAME UNIV CALIFORNIA (US) 2025-10-30 US claimed
WO-2010129672-A1 LIPOPHILIC POLYNUCLEOTIDE CONJUGATES MIRAGEN THERAPEUTICS (US) 2010-11-11 WO claimed
US-20100260676-A1 PRECISION-GUIDED NANOPARTICLE SYSTEMS FOR DRUG DELIVERY NORTHEASTERN UNIVERSITY (US) 2010-10-14 US claimed
WO-2010095044-A2 MEDICAL DEVICE WITH DEGRADATION-RETARDING COATING SOFRADIM PRODUCTION (FR) 2010-08-26 WO claimed
WO-2010095058-A2 MEDICAL DEVICE WITH INFLAMMATORY RESPONSE-REDUCING COATING SOFRADIM PRODUCTION (FR) 2010-08-26 WO claimed
US-20090137060-A1 MULTICOLORED PARTICLES RIKSHOSPITALET HF (NO) 2009-05-28 US claimed
WO-2008147481-A1 PRECISION-GUIDED NANOPARTICLE SYSTEMS FOR DRUG DELIVERY NORTHEASTERN UNIVERSITY (US) 2008-12-04 WO claimed
US-20080182336-A1 light-emitting molecular entity, capable of being switched between a first state able to emit light at a first, emission wavelength and a second state that does not substantially emit light; photoswitchable PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2008-07-31 US claimed
EP-1904841-A1 MULTICOLORED PARTICLES Rikshospitalet-Radiumhospitalet HF (NO) 2008-04-02 EP claimed
WO-2007008084-A1 MULTICOLORED PARTICLES RIKSHOSPITALET-RADIUMHOSPITALET HF (NO) 2007-01-18 WO claimed
WO-2005094757-A1 DENTAL SEALANT COMPOSITION FOR THE PROTECTION OF HARD TISSUE DENTSPLY DE TREY GMBH (DE) 2005-10-13 WO claimed